1 Chobanian, AV (1991) Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 18, 130–131.
2 Drake, TA, Hannani, K, Fei, HH, Lavi, S & Berliner, JA (1991) Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Pathol 138, 601–607.
3 Steinberg, D (1997) Oxidative modification of LDL and atherogenesis. Circulation 95, 1062–1071.
4 Esterbauer, H, Gebicki, J, Puhl, H & Jurgens, G (1992) The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 13, 341–390.
5 Sparrow, CP, Parthasarathy, S & Steinberg, D (1989) A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 264, 2599–2604.
6 Berliner, JA, Territo, MC, Sevanian, A, et al. (1990) Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85, 1260–1266.
7 Rajavahira, TB, Andalibi, A, Territo, MC, Berliner, JA, Navab, M, Fogelman, AM & Lusis, AJ (1990) Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature 344, 254–257.
8 Palinski, W, Rosenfeld, ME, Yla-Herttuala, S, et al. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 86, 1372–1376.
9 Craig, W (1995) Autoantibodies against oxidized low density lipoportein: a review of clinical findings and assay methodology. J Clin Lab Anal 9, 70–74.
10 Karabinos, IK, Koulouris, S, Melpidou, A, et al. (2003) Increased serum titers of autoantibodies against oxidized LDL cholesterol in young healthy adults: an evidence of a protective effect of these antibodies? Hellenic J Cardiol 44, 374–384.
11 Lehtimaki, T, Lehtinen, S, Solakivi, T, et al. (1999) Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. Arterioscler Thromb Vasc Biol 19, 23–27.
12 Inoue, T, Uchida, T, Kamishirado, H, et al. (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 775–779.
13 Shoji, T, Nishizawa, Y, Fukumoto, M, et al. (2000) Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148, 171–177.
14 Yla-Herttuala, S, Palinski, W, Rosenfeld, ME, et al. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086–1095.
15 Abbey, M, Belling, GB, Noakes, M, Hirata, F & Nestel, PJ (1993) Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 57, 391–398.
16 Reaven, PD, Parthasarathy, S, Grasse, BJ, Miller, E, Steinberg, D & Witztum, J (1993) Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91, 668–676.
17 Gradek, WQ, Harris, MT, Yahia, N, Davis, WW, Le, NA & Brown, WV (2004) Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease. Am J Cardiol 93, 881–885.
18 Le, NA, Li, X, Kyung, S & Brown, WV (2000) Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium. Metabolism 49, 1271–1277.
19 Folch, J, Lees, M & Sloane Stanley, GM (1957) A simple method for the isolation and purification of total lipides from animal tissue. J Biol Chem 226, 497–509.
20 Lepage, G & Roy, CC (1986) Direct tranesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114–120.
21 Tinahones, FJ, Gomez-Zumaquero, JM, Rojo-Martinez, G, et al. (2002) Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism 51, 429–431.
22 Tinahones, FJ, Gomez-Zumaquero, JM, Garrido-Sanchez, L, et al. (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46, 452–457.
23 Balada, E, Ordi-Ros, J, Matas, L, Mauri, M, Bujan, S & Vilardell-Tarres, M (2002) Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population. Med Clin (Barc) 119, 161–165.
24 Festa, A, Kopp, HP, Schernthaner, G & Menzel, EJ (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41, 350–356.
25 Karvonen, J, Paivansalo, M, Kesaniemi, YA & Horkko, S (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108, 2107–2112.
26 Horkko, S, Bird, DA, Miller, E, et al. (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103, 117–128.
27 Freigang, S, Horkko, S, Miller, E, Witztum, JL & Palinski, W (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18, 1972–1982.
28 GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
29 Burr, ML, Fehily, AM, Gilbert, JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet ii, 757–761.
30 Schmidt, EB, Kristensen, SD, De Caterina, R & Illingworth, DR (1993) The effects of n-3 fatty acids on plasma lipids and lipoproteins and the other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107–121.
31 Levine, PH, Fisher, N, Schneider, PB, et al. (1989) Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 149, 1113–1116.
32 Singer, P, Wirth, M, Berger, I, et al. (1985) Influence of serum lipids, lipoproteins and blood pressure of mackerel and herring diet in patients with type IV and V hyperlipoproteinemia. Atherosclerosis 56, 111–118.
33 Green, P, Fuchs, J & Schoenfeld, N (1990) Effects of fish oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: a randomized, double-blind crossover study. Am J Clin Nutr 52, 1118–1124.
34 Kinsella, JE, Lokesh, B & Stone, RA (1990) Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 52, 1–28.
35 Witztum, JL & Steinberg, D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88, 1785–1792.
36 Tsai, PJ & Lu, SC (1997) Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men. J Form Med Assoc 96, 718–726.
37 Suzukawa, M, Ishikawa, T, Yoshida, H & Nakamura, H (1995) Effect of in vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14, 46–52.
38 Higdon, JV, Du, SH, Lee, YS, Wu, T & Wander, RC (2001) Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J Lipid Res 42, 407–418.
39 Mesa, MD, Buckley, R, Marieinibane, A & Yaqoob, R (2004) Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on theoxidizability and thrombogenicity of low-density lipoprotein. Atherosclerosis 175, 333–343.
40 Nomura, S, Kanazawa, S & Fukuhara, S (2003) Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabetes Complications 17, 153–159.
41 Johansen, O, Seljeflot, I, Hostmark, AT & Arnesen, H (1999) The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19, 1681–1686.
42 Thies, F, Miles, EA, Nebe-von-Caron, G, et al. (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36, 1183–1193.
43 Aguilera, CM, Ramirez-Tortosa, MC, Mesa, MD, Ramirez-Tortosa, CL & Gil, A (2002) Sunflower, virgin-olive and fish oils differentially affect the progression of aortic lesions in rabbits with experimental atherosclerosis. Atherosclerosis 162, 335–344.
44 Hu, FB, Bronner, L, Willett, WC, et al. (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815–1821.
45 Harris, WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30, 785–807.
46 Alexander, JW (1998) Immunonutrition: the role of omega-3 fatty acids. Nutrition 14, 627–633.
47 Simopoulos, AP (1991) Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54, 438–463.